{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:07:03Z","timestamp":1790842023218,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["ERT-155725"],"award-info":[{"award-number":["ERT-155725"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Premature termination codon (PTC) readthrough is considered a potential treatment for genetic diseases caused by nonsense mutations. High concentrations of aminoglycosides induce low levels of PTC readthrough but also elicit severe toxicity. Identifying compounds that enhance PTC readthrough by aminoglycosides or reduce their toxicity is a continuing challenge. In humans, a binary complex of eukaryotic release factors 1 (eRF1) and 3 (eRF3a or eRF3b) mediates translation termination. They also participate in the SURF (SMG1-UPF1-eRF1-eRF3) complex assembly involved in nonsense-mediated mRNA decay (NMD). We show that PTC readthrough by aminoglycoside G418 is considerably enhanced by eRF3a and eRF3b siRNAs and cereblon E3 ligase modulators CC-885 and CC-90009, which induce proteasomal degradation of eRF3a and eRF3b. eRF3 degradation also reduces eRF1 levels and upregulates UPF1 and selectively stabilizes TP53 transcripts bearing a nonsense mutation over WT, indicating NMD suppression. CC-90009 is considerably less toxic than CC-885 and it enhances PTC readthrough in combination with aminoglycosides in mucopolysaccharidosis type I-Hurler, late infantile neuronal ceroid lipofuscinosis, Duchenne muscular dystrophy and junctional epidermolysis bullosa patient-derived cells with nonsense mutations in the IDUA, TPP1, DMD and COL17A1 genes, respectively. Combination of CC-90009 with aminoglycosides such as gentamicin or ELX-02 may have potential for PTC readthrough therapy.<\/jats:p>","DOI":"10.1093\/nar\/gkab194","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T15:13:21Z","timestamp":1615389201000},"page":"3692-3708","source":"Crossref","is-referenced-by-count":81,"title":["Effect of small molecule eRF3 degraders on premature termination codon readthrough"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-4907","authenticated-orcid":false,"given":"Alireza","family":"Baradaran-Heravi","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna D","family":"Balgi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hosseini-Farahabadi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunho","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Has","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Roberge","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"2021070811530517300_B1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/humu.20763","article-title":"A meta-analysis of nonsense mutations causing human genetic disease","volume":"29","author":"Mort","year":"2008","journal-title":"Hum. Mutat."},{"key":"2021070811530517300_B2","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1074\/jbc.M113.533588","article-title":"Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases","volume":"289","author":"Shulman","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2021070811530517300_B3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity","volume":"27","author":"Wargo","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"2021070811530517300_B4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","article-title":"Aminoglycoside induced ototoxicity","volume":"249","author":"Guthrie","year":"2008","journal-title":"Toxicology"},{"key":"2021070811530517300_B5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-020-00369-5","article-title":"Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency","volume":"15","author":"Frew","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"2021070811530517300_B6","doi-asserted-by":"crossref","first-page":"e0216423","DOI":"10.1371\/journal.pone.0216423","article-title":"The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418","volume":"14","author":"Ferguson","year":"2019","journal-title":"PLoS One"},{"key":"2021070811530517300_B7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsmedchemlett.8b00610","article-title":"2-Aminothiazole-4-carboxamides enhance readthrough of premature termination codons by aminoglycosides","volume":"10","author":"Rabea","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"2021070811530517300_B8","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1093\/nar\/gkw638","article-title":"Novel small molecules potentiate premature termination codon readthrough by aminoglycosides","volume":"44","author":"Baradaran-Heravi","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"2021070811530517300_B9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbagrm.2017.04.004","article-title":"Exploring contacts of eRF1 with the 3\u2032-terminus of the P site tRNA and mRNA stop signal in the human ribosome at various translation termination steps","volume":"1860","author":"Bulygin","year":"2017","journal-title":"Biochim. Biophys. Acta - Gene Regul. Mech."},{"key":"2021070811530517300_B10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/372701a0","article-title":"A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor","volume":"372","author":"Frolova","year":"1994","journal-title":"Nature"},{"key":"2021070811530517300_B11","doi-asserted-by":"crossref","first-page":"22254","DOI":"10.1074\/jbc.273.35.22254","article-title":"Molecular cloning of a novel member of the eukaryotic polypeptide chain- releasing factors (eRF): Its identification as eRF3 interacting with eRF1","volume":"273","author":"Hoshino","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021070811530517300_B12","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/j.1460-2075.1989.tb08558.x","article-title":"A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells","volume":"8","author":"Hoshino","year":"1989","journal-title":"EMBO J."},{"key":"2021070811530517300_B13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1023\/A:1010527127440","article-title":"[Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo","volume":"35","author":"Jakobsen","year":"2001","journal-title":"Mol. Biol. (Mosk)."},{"key":"2021070811530517300_B14","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"2021070811530517300_B15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.1389006","article-title":"Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay","volume":"20","author":"Kashima","year":"2006","journal-title":"Genes Dev."},{"key":"2021070811530517300_B16","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/MCB.24.17.7769-7778.2004","article-title":"GTP Hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination","volume":"24","author":"Salas-Marco","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2021070811530517300_B17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2958.1996.tb02634.x","article-title":"Depletion in the levels of the release factor eRF1 causes a reduction in the efficiency of translation termination in yeast","volume":"20","author":"Stansfield","year":"1996","journal-title":"Mol. Microbiol."},{"key":"2021070811530517300_B18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1261\/rna.5280103","article-title":"Stop codon suppression via inhibition of eRF1 expression","volume":"9","author":"Carnes","year":"2003","journal-title":"RNA"},{"key":"2021070811530517300_B19","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1128\/MCB.25.14.5801-5811.2005","article-title":"Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation","volume":"25","author":"Chauvin","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"2021070811530517300_B20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/nat.2019.0779","article-title":"Targeting translation termination machinery with antisense oligonucleotides for diseases caused by nonsense mutations","volume":"29","author":"Huang","year":"2019","journal-title":"Nucleic Acid Ther."},{"key":"2021070811530517300_B21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.11.011","article-title":"RNA therapy: are we using the right molecules","volume":"196","author":"Yu","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"2021070811530517300_B22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4 CRBN ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature"},{"key":"2021070811530517300_B23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood-2019-125492","article-title":"Elucidating the mechanism of action of CC-90009, a novel cereblon E3 ligase modulator, in AML via genome-wide CRISPR screen","volume":"134","author":"Lu","year":"2019","journal-title":"Blood"},{"key":"2021070811530517300_B24","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2019-127892","article-title":"CC-90009, a novel cereblon E3 ligase modulator, targets GSPT1 for degradation to induce potent tumoricidal activity against acute myeloid leukemia (AML)","volume":"134","author":"Lopez-Girona","year":"2019","journal-title":"Blood"},{"key":"2021070811530517300_B25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1182\/blood-2019-123966","article-title":"Clinical activity of CC-90009, a cereblon E3 ligase modulator and first-in-class GSPT1 degrader, as a single agent in patients with relapsed or refractory acute myeloid leukemia (R\/R AML): first results from a Phase I dose-finding study","volume":"134","author":"Uy","year":"2019","journal-title":"Blood"},{"key":"2021070811530517300_B26","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2019-128450","article-title":"A novel cereblon E3 ligase modulator eradicates acute myeloid leukemia stem cells through degradation of translation termination factor GSPT1","volume":"134","author":"Jin","year":"2019","journal-title":"Blood"},{"key":"2021070811530517300_B27","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1182\/blood-2019-124291","article-title":"Pharmacodynamic responses to CC-90009, a novel cereblon E3 ligase modulator, in a phase I dose-escalation study in relapsed or refractory acute myeloid leukemia (R\/R AML)","volume":"134","author":"Fan","year":"2019","journal-title":"Blood"},{"key":"2021070811530517300_B28","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/sctm.16-0449","article-title":"Liver-directed human amniotic epithelial cell transplantation improves systemic disease phenotype in Hurler syndrome mouse model","volume":"6","author":"Rodriguez","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"2021070811530517300_B29","doi-asserted-by":"crossref","first-page":"17914","DOI":"10.1074\/jbc.M100728200","article-title":"Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine","volume":"276","author":"Curman","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021070811530517300_B30","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1093\/nar\/gkq1277","article-title":"Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides","volume":"39","author":"Floquet","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"2021070811530517300_B31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3892\/ijo.2013.2149","article-title":"Proteasome inhibitors and knockdown of SMG1 cause accumulation of Upf1 and Upf2 in human cells","volume":"44","author":"Zhao","year":"2014","journal-title":"Int. J. Oncol."},{"key":"2021070811530517300_B32","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1261\/rna.030247.111","article-title":"Autoregulation of the nonsense-mediated mRNA decay pathway in human cells","volume":"17","author":"Yepiskoposyan","year":"2011","journal-title":"RNA"},{"key":"2021070811530517300_B33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.molcel.2011.06.031","article-title":"RNA homeostasis governed by cell type-specific and branched feedback loops acting on NMD","volume":"43","author":"Huang","year":"2011","journal-title":"Mol. Cell"},{"key":"2021070811530517300_B34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/15476286.2019.1674595","article-title":"Divergent effects of translation termination factor eRF3A and nonsense-mediated mRNA decay factor UPF1 on the expression of uORF carrying mRNAs and ribosome protein genes","volume":"17","author":"Aliouat","year":"2020","journal-title":"RNA Biol"},{"key":"2021070811530517300_B35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood.2020008676","article-title":"CC-90009, a novel cereblon E3 ligase modulator targets acute myeloid leukemia blasts and leukemia stem cells","volume":"137","author":"Surka","year":"2021","journal-title":"Blood"},{"key":"2021070811530517300_B36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tips.2009.11.002","article-title":"Recent advances and method development for drug target identification","volume":"31","author":"Chan","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"2021070811530517300_B37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/6791","article-title":"Genomic profiling of drug sensitivities via induced haploinsufficiency","volume":"21","author":"Giaever","year":"1999","journal-title":"Nat. Genet."},{"key":"2021070811530517300_B38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chembiol.2004.10.015","article-title":"A genome-wide overexpression screen in yeast for small-molecule target identification","volume":"12","author":"Luesch","year":"2005","journal-title":"Chem. Biol."},{"key":"2021070811530517300_B39","doi-asserted-by":"crossref","first-page":"e1002608","DOI":"10.1371\/journal.pgen.1002608","article-title":"Statistical analysis of readthrough levels for nonsense mutations in mammalian cells reveals a major determinant of response to gentamicin","volume":"8","author":"Floquet","year":"2012","journal-title":"PLos Genet."},{"key":"2021070811530517300_B40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","article-title":"Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAS in a mammalian translation system","volume":"80","author":"Keeling","year":"2002","journal-title":"J. Mol. Med."},{"key":"2021070811530517300_B41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B","article-title":"Sequence specificity of aminoglycoside-induced stop codon readthrough: Potential implications for treatment of Duchenne muscular dystrophy","volume":"48","author":"Howard","year":"2000","journal-title":"Ann. Neurol."},{"key":"2021070811530517300_B42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ymgme.2013.05.016","article-title":"Residual \u03b1-l-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients","volume":"109","author":"Oussoren","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"2021070811530517300_B43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis","volume":"94","author":"Sleat","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"2021070811530517300_B44","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1172\/JCI92707","article-title":"Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients","volume":"127","author":"Woodley","year":"2017","journal-title":"J. Clin. Invest."},{"key":"2021070811530517300_B45","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ymthe.2020.03.006","article-title":"Gentamicin induces laminin 332 and improves wound healing in junctional epidermolysis bullosa patients with nonsense mutations","volume":"28","author":"Kwong","year":"2020","journal-title":"Mol. Ther."},{"key":"2021070811530517300_B46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000499906","article-title":"Attenuation of severe generalized junctional epidermolysis bullosa by systemic treatment with gentamicin","volume":"235","author":"Hammersen","year":"2019","journal-title":"Dermatology"},{"key":"2021070811530517300_B47","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1111\/1346-8138.15230","article-title":"Gentamicin induces COL17A1 nonsense mutation readthrough in junctional epidermolysis bullosa","volume":"47","author":"Li","year":"2020","journal-title":"J. Dermatol."},{"key":"2021070811530517300_B48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-genom-091212-153527","article-title":"Therapeutics based on stop codon readthrough","volume":"15","author":"Keeling","year":"2014","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"2021070811530517300_B49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/jpet.120.265595","article-title":"ELX-02 generates protein via premature stop codon read-through without inducing native stop codon read-through proteins","volume":"374","author":"Crawford","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021070811530517300_B50","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15476286.2017.1285480","article-title":"Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells","volume":"14","author":"Bidou","year":"2017","journal-title":"RNA Biol"},{"key":"2021070811530517300_B51","doi-asserted-by":"crossref","first-page":"e52611","DOI":"10.7554\/eLife.52611","article-title":"Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides","volume":"9","author":"Wangen","year":"2020","journal-title":"Elife"},{"key":"2021070811530517300_B52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1750-1172-7-58","article-title":"Rescue of nonsense mutations by amlexanox in human cells","volume":"7","author":"Gonzalez-Hilarion","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"2021070811530517300_B53","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1158\/0008-5472.CAN-13-2235","article-title":"Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations","volume":"74","author":"Martin","year":"2014","journal-title":"Cancer Res."},{"key":"2021070811530517300_B54","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1128\/MCB.00035-07","article-title":"Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway","volume":"27","author":"Chauvin","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"2021070811530517300_B55","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.febslet.2015.06.041","article-title":"Calpain mediates processing of the translation termination factor eRF3 into the IAP-binding isoform p-eRF3","volume":"589","author":"Hashimoto","year":"2015","journal-title":"FEBS Lett."},{"key":"2021070811530517300_B56","doi-asserted-by":"crossref","first-page":"38699","DOI":"10.1074\/jbc.M303179200","article-title":"The polypeptide chain-releasing factor GSPT1\/eRF3 is proteolytically processed into an IAP-binding protein","volume":"278","author":"Hegde","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021070811530517300_B57","doi-asserted-by":"crossref","first-page":"26171","DOI":"10.18632\/oncotarget.25459","article-title":"Translation termination-dependent deadenylation of MYC mRNA in human cells","volume":"9","author":"Jolles","year":"2018","journal-title":"Oncotarget"},{"key":"2021070811530517300_B58","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1093\/nar\/gkaa136","article-title":"Translational read-through promotes aggregation and shapes stop codon identity","volume":"48","author":"Kramarski","year":"2020","journal-title":"Nucleic Acids Res."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/7\/3692\/37123629\/gkab194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/article-pdf\/49\/7\/3692\/37123629\/gkab194.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T16:44:58Z","timestamp":1625762698000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/49\/7\/3692\/6188348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,3,25]]},"published-print":{"date-parts":[[2021,4,19]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkab194","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,19]]},"published":{"date-parts":[[2021,3,25]]}}}